Results 1 to 10 of about 256,425 (387)

Sorghum Protein Extract Protects RBC from Sodium Nitrite-Induced Oxidative Stress and Exhibits Anticoagulant and Antiplatelet Activity [PDF]

open access: yesFolia Medica, 2021
Introduction: Oxidative stress plays a critical role in the progression of diabetes, arthritis, cancer, eryptosis, cardiovascular disease, and thrombosis. Currently, antioxidants from natural sources are in high demand due to their beneficial role in the
Devaraja Sannaningaiah   +10 more
doaj   +3 more sources

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial

open access: yesFrontiers in Cardiovascular Medicine, 2021
Aims: In this pre-specified analysis of the “endothelium, stent and antiplatelet therapy” study, we investigate the impact of antiplatelet therapies on microvascular function in patients undergoing stenting for an acute coronary syndrome.Methods and ...
Boris Schnorbus   +7 more
doaj   +1 more source

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 2018
The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC)and of the European Association for Cardio-Thoracic Surgery(EACTS)
M. Valgimigli   +17 more
semanticscholar   +3 more sources

Bridging therapy according to new clinical guidelines: A review

open access: yesConsilium Medicum, 2022
In modern world it is really important to know how to manage patients taking anticoagulant or antiplatelet therapy. There is an increasing number of patients, who have gone through PCI or any other cardiac intervention and who also need another surgery ...
Tatiana A. Pavlenko   +2 more
doaj   +1 more source

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear.
M. Valgimigli   +29 more
semanticscholar   +1 more source

The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors

open access: yesFrontiers in Immunology, 2022
Patients with COVID-19 often have hypoxemia, impaired lung function, and abnormal imaging manifestations in acute and convalescent stages. Alveolar inflammation, pulmonary vasculitis, and thromboembolism synergistically damage the blood-air barrier ...
Mengqi Xiang   +9 more
doaj   +1 more source

Antiplatelet drugs [PDF]

open access: yesBritish Journal of Pharmacology, 2006
British Journal of Pharmacology (2006) 147, S241–S251.
Gustav, Born, Carlo, Patrono
openaire   +2 more sources

Antiplatelet drugs [PDF]

open access: yesBritish Journal of Haematology, 2008
SummaryPlatelets play a major role in thromboembolic diseases, and so antiplatelet therapy remains crucial in treatment and prophylaxis. Upon vascular injury, platelets rapidly adhere to the exposed subendothelial matrix, after which they become activated, resulting in the recruitment of additional platelets from the circulation to eventually form a ...
Simon F, De Meyer   +4 more
openaire   +2 more sources

Dual Antiplatelet Therapy: A Concise Review for Clinicians

open access: yesLife, 2023
Dual antiplatelet therapy (DAPT) combines two antiplatelet agents to decrease the risk of thrombotic complications associated with atherosclerotic cardiovascular diseases. Emerging data about the duration of DAPT is being published continuously.
H. H. Virk   +9 more
semanticscholar   +1 more source

Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum

open access: yesPlatelets, 2023
Chronic kidney disease (CKD) is a global health problem and an independent risk factor for cardiovascular morbidity and mortality. Despite evidence-based therapies significantly improving cardiovascular mortality outcomes in the general population and ...
Frances L. Varian   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy